IRIS
DE PLACIDO, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 555
EU - Europa 392
AS - Asia 77
AF - Africa 27
Totale 1.051
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 545
IT - Italia 286
NL - Olanda 55
CI - Costa d'Avorio 27
IN - India 26
CN - Cina 23
DE - Germania 16
CA - Canada 9
VN - Vietnam 8
GB - Regno Unito 7
PK - Pakistan 7
BE - Belgio 5
UA - Ucraina 5
AL - Albania 3
FI - Finlandia 3
FR - Francia 3
IR - Iran 3
SE - Svezia 3
JP - Giappone 2
MY - Malesia 2
PH - Filippine 2
RS - Serbia 2
AT - Austria 1
BZ - Belize 1
ES - Italia 1
GR - Grecia 1
MC - Monaco 1
NP - Nepal 1
SG - Singapore 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.051
Salva come PNG Salva come JPEG
Città #
Chandler 136
Naples 70
Ashburn 55
Amsterdam 54
Millbury 29
Lawrence 26
Pune 20
Napoli 19
Rome 19
Des Moines 17
Beijing 14
Casoria 12
Wilmington 10
Boston 8
Dong Ket 8
Ottawa 8
Milan 7
Redwood City 6
Seattle 6
Bologna 5
Fairfield 4
Fucecchio 4
Kortrijk 4
Kronberg 4
Salerno 4
Sciacca 4
Turin 4
Veroli 4
Ardabil 3
Casagiove 3
Chiaravalle Centrale 3
Lahore 3
Lappeenranta 3
Luco dei Marsi 3
New York 3
Pellezzano 3
Pomigliano d'Arco 3
Sant'Agnello 3
Tirana 3
Augusta 2
Boardman 2
Edinburgh 2
Formello 2
Formia 2
General Mariano Alvarez 2
Islamabad 2
Jacksonville 2
Kochi 2
Krefeld 2
Kuala Lumpur 2
Leawood 2
Locate di Triulzi 2
Lomazzo 2
Nashville 2
Novi Sad 2
Palermo 2
Piana 2
Prato 2
Rawalpindi 2
Rovereto 2
San Giorgio a Cremano 2
San Mateo 2
Sennori 2
Shanghai 2
Shenyang 2
Teano 2
Washington 2
Woodbridge 2
Athens 1
Bacoli 1
Bad Bellingen 1
Belize City 1
Caivano 1
Casalnuovo Di Napoli 1
Caserta 1
Dearborn 1
Deiva Marina 1
Falkenstein 1
Fisciano 1
Forlì 1
Frankfurt am Main 1
Granada 1
Gunzenhausen 1
Hebei 1
Houston 1
Jiaxing 1
Kagoya 1
Kathmandu 1
La Louvière 1
Lanuvio 1
Macerata Campania 1
Manassas 1
Marigliano 1
Mirabella Eclano 1
Modugno 1
Monaco 1
Monmouth Junction 1
Montalbano Jonico 1
Montemiletto 1
Mountain View 1
Totale 684
Salva come PNG Salva come JPEG
Nome #
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors. 60
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 52
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 51
A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA 44
Mechanisms of resistance to mTOR inhibitors 42
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. 41
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 40
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 39
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial 38
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 38
Use of folfirinox or nab-paclitaxel plus gemcitabine for the treatment of locally advanced pancreatic adenocarcinoma: A single institution observational study 38
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis 37
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis 36
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer 35
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 34
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 33
Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie 31
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 29
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 29
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 28
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: a systematic review 27
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug? 26
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype 26
The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer 26
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer 25
Tumour microenvironment and immune evasion in EGFR addicted NSCLC: Hurdles and possibilities 24
Prevalence of Sarcopenia in Women with Breast Cancer 23
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 23
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational study 20
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis 17
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/her2‐negative metastatic breast cancer: Systematic review and meta‐analysis 17
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 15
Extraskeletal Ewing's sarcoma of the mediastinum: Case report 14
Statin use and survival in patients with metastatic castrationresistant prostate cancer treated with abiraterone or enzalutamide after docetaxel failure: The international retrospective observational STABEN study 12
Immunological signature of patients with thymic epithelial tumors and Good syndrome 12
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study 11
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 10
BRAF Gene and Melanoma: Back to the Future 10
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response 8
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer 6
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 5
Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors 2
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 1
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 1
Totale 1.136
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 6 1 2 3 7 9 0 7 2 3 19 4
2020/2021124 6 1 0 1 13 16 17 9 24 1 18 18
2021/2022215 6 3 11 7 2 5 11 9 7 22 70 62
2022/2023397 34 34 14 17 36 39 14 43 51 78 21 16
2023/2024319 15 53 59 39 19 57 6 50 8 5 8 0
Totale 1.136